1 The most common adverse event leading to discontinuation was gastrointestinal disorders, occurring in 10% of patients in the Wegovy group and 2% in the placebo group
The drug is currently being studied in clinical trials for the treatment of obesity, overweight with weight-related comorbidities, and type 2 diabetes
Acne, wrinkles, and other signs of aging are caused by these free radicals damaging skin cells
Your doctor designs a personalised clinical-grade protocol, selecting the right medication (semaglutide, tirzepatide or an alternative), setting the starting dose and mapping out the titration schedule
These pathways include the modulation of gut hormone release, neural communication between the gut and brain, immune system signaling, and metabolic networks in the host